U.S., May 28 -- ClinicalTrials.gov registry received information related to the study (NCT07610226) titled 'Post-refractive IOL Outcomes With Clareon TruPlus' on May 20.
Brief Summary: This is a prospective, single-arm, single-center, single-surgeon study evaluating the Clareon TruPlus IOL in post-refractive cataract patients. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the PRISQ Questionnaire.
Study Start Date: June 23
Study Type: OBSERVATIONAL
Condition:
Cataract
Intervention:
DEVICE: Clareon TruPlus
Clareon TruPlus
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Laser Defined Vision
Published by HT Digital Content Service...